Zachariah DeFilipp

6.7k total citations · 1 hit paper
106 papers, 2.0k citations indexed

About

Zachariah DeFilipp is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Zachariah DeFilipp has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 38 papers in Oncology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Zachariah DeFilipp's work include Hematopoietic Stem Cell Transplantation (41 papers), Cancer survivorship and care (18 papers) and Childhood Cancer Survivors' Quality of Life (16 papers). Zachariah DeFilipp is often cited by papers focused on Hematopoietic Stem Cell Transplantation (41 papers), Cancer survivorship and care (18 papers) and Childhood Cancer Survivors' Quality of Life (16 papers). Zachariah DeFilipp collaborates with scholars based in United States, Canada and United Kingdom. Zachariah DeFilipp's co-authors include Yi‐Bin Chen, Elizabeth Hohmann, Patricia P. Bloom, Sarah E. Turbett, Michael K. Mansour, Miriam Huntley, Mariam Torres Soto, Raymond T. Chung, Mohamad Sater and Areej El‐Jawahri and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zachariah DeFilipp

84 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

2019 827 citations Zachariah DeFilipp, Yi‐Bin Chen et al. profile →

Peers

Countries citing papers authored by Zachariah DeFilipp

Since Specialization

Citations

This map shows the geographic impact of Zachariah DeFilipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachariah DeFilipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachariah DeFilipp more than expected).

Fields of papers citing papers by Zachariah DeFilipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachariah DeFilipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachariah DeFilipp. The network helps show where Zachariah DeFilipp may publish in the future.

Co-authorship network of co-authors of Zachariah DeFilipp

This figure shows the co-authorship network connecting the top 25 collaborators of Zachariah DeFilipp. A scholar is included among the top collaborators of Zachariah DeFilipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachariah DeFilipp. Zachariah DeFilipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Study of Peri- and Post-Transplant Ruxolitinib for Patients With Myelofibrosis Receiving Allogeneic Hematopoietic Cell Transplantation 2025 ·Gabriela Hobbs, Haesook T. Kim, (unknown), Mark A. Schroeder, Roni Tamari, Sarah Wall, (unknown), Areej El‐Jawahri, Matthew J. Frigault, Steven L. McAfee, Richard Newcomb, Paul V. O’Donnell, Thomas R. Spitzer, Jonas S. Jutzi, Yi‐Bin Chen, Zachariah DeFilipp	1
2	RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT 2025 ·Blood ·Zachariah DeFilipp, Hannah Choe, Yvonne A. Efebera, Ayman Saad, (unknown), Lazaros J. Lekakis, Jean A. Yared, Gary J. Schiller, Markus Y. Mapara, Amer Assal, Ted Gooley, Jack D. Bui, (unknown), (unknown), Yi‐Bin Chen	1
3	Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation 2025 ·Journal of Clinical Oncology ·Areej El‐Jawahri, Thomas W. LeBlanc, (unknown), Jason A. Webb, James Fausto, Lara Traeger, Joseph A. Greer, Vicki A. Jackson, Nora Horick, Dustin J. Rabideau, (unknown), Richard Newcomb, Nneka N. Ufere, (unknown), (unknown), Zachariah DeFilipp, Yi‐Bin Chen, Stephanie J. Lee, Jennifer S. Temel	0
4	BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation 2025 ·Journal of Clinical Oncology ·Jamie M. Jacobs, Lara Traeger, (unknown), Anna Barata, Richard Newcomb, Dustin J. Rabideau, Nora Horick, Zachariah DeFilipp, Yi‐Bin Chen, Tamryn F. Gray, (unknown), (unknown), Hermioni L. Amonoo, Stephanie J. Lee, Joseph A. Greer, Jennifer S. Temel, Areej El‐Jawahri	0
5	Randomized Trial of a Multimodal Intervention to Enhance Sexual Function and Quality of Life (QOL) in Hematopoietic Stem Cell Transplant (HSCT) Survivors 2024 ·Transplantation and Cellular Therapy ·Areej El‐Jawahri, Jennifer Barsky Reese, Lara Traeger, Don S. Dizon, Sharon L. Bober, (unknown), Nora Horick, (unknown), Zachariah DeFilipp, Yibin Chen, Jennifer S. Temel	0
6	Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors 2024 ·Transplantation and Cellular Therapy ·Richard Newcomb, Lara Traeger, (unknown), (unknown), (unknown), Jennifer Barsky Reese, Don S. Dizon, Sharon L. Bober, Joseph A. Greer, (unknown), Nicole Pensak, Zachariah DeFilipp, Yi‐Bin Chen, Jennifer S. Temel, Areej El‐Jawahri	2
7	Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects 2024 ·Transplantation and Cellular Therapy ·Richard Newcomb, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew J. Frigault, Steven L. McAfee, Thomas R. Spitzer, Zachariah DeFilipp, (unknown), Hermioni L. Amonoo, Areej El‐Jawahri	0
8	ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy 2024 ·Transplantation and Cellular Therapy ·Hamza Hashmi, Ambuj Kumar, Mohamed A. Kharfan‐Dabaja, Pashna N. Munshi, Yoshihiro Inamoto, Zachariah DeFilipp, Bhagirathbhai Dholaria, Tania Jain, Miguel‐Angel Perales, Paul A. Carpenter, Mehdi Hamadani, Binod Dhakal, Saad Z. Usmani	1
9	A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT 2024 ·Blood Advances ·Zachariah DeFilipp, Haesook T. Kim, Guang‐Shing Cheng, Betty K. Hamilton, Saurabh Chhabra, Mehdi Hamadani, Karamjeet Sandhu, Lia Perez, Catherine J. Lee, (unknown), (unknown), (unknown), Kathleen Gallagher, Richard Newcomb, Areej El‐Jawahri, Yi‐Bin Chen	3
10	Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD 2023 ·Blood ·(unknown), Michael J. Raabe, (unknown), (unknown), Chenyue Lu, Vikram Deshpande, Linda T. Nieman, Martin J. Aryee, Yi‐Bin Chen, David T. Ting, Zachariah DeFilipp	0
11	How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? 2023 ·Blood Reviews ·Mark Juckett, Christopher E. Dandoy, Zachariah DeFilipp, Tamila L. Kindwall‐Keller, Stephen R. Spellman, Celalettin Üstün, (unknown), Daniel J. Weisdorf, William A. Wood, Mary M. Horowitz, Linda J. Burns, Nandita Khera	1
12	Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy 2023 ·Transplantation and Cellular Therapy ·Abraham S. Kanate, Navneet S. Majhail, Zachariah DeFilipp, Binod Dhakal, Bhagirathbhai Dholaria, Betty K. Hamilton, Alex F. Herrera, Yoshihiro Inamoto, Tania Jain, Miguel‐Angel Perales, Paul A. Carpenter, Mehdi Hamadani	25
13	Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Richard Newcomb, P. Connor Johnson, (unknown), (unknown), (unknown), (unknown), (unknown), Dustin J. Rabideau, Zachariah DeFilipp, Yi‐Bin Chen, Areej El‐Jawahri	10
14	AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients 2023 ·Bone Marrow Transplantation ·(unknown), (unknown), Samuel Short, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Charlotte Thomas, (unknown), Dylan J. Martini, Richard Newcomb, Roman M. Shapiro, Robert J. Soiffer, Zachariah DeFilipp, Rebecca M. Baron, Shruti Gupta, Meghan E. Sise, David E. Leaf	3
15	Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCT 2022 ·Transplantation and Cellular Therapy ·Zachariah DeFilipp, Haesook T. Kim, Laura Knight, (unknown), Michael Byrne, Mark A. Schroeder, Roni Tamari, Sarah Wall, Sumithira Vasu, Sameem Abedin, Areej El‐Jawahri, Steven L. McAfee, Yi‐Bin Chen, Gabriela Hobbs	2
16	ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy 2022 ·Transplantation and Cellular Therapy ·Nausheen Ahmed, Ambuj Kumar, Mohamed A. Kharfan‐Dabaja, Zachariah DeFilipp, Alex F. Herrera, Shahrukh K. Hashmi, Bhagirathbhai Dholaria, Miguel‐Angel Perales, Paul A. Carpenter, Mehdi Hamadani	14
17	Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis 2021 ·British Journal of Haematology ·Sameem Abedin, (unknown), Mark A. Schroeder, Rizwan Romee, (unknown), Muhamad Alhaj Moustafa, Mohamed A. Kharfan‐Dabaja, Jeanne Palmer, William J. Hogan, Mehrdad Hefazi, (unknown), Shernan G. Holtan, Zachariah DeFilipp, Reena Jayani, Bhagirathbhai Dholaria, Joseph Pidala, Farhad Khimani, Michael R. Grunwald, (unknown), Mehdi Hamadani	10
18	Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial 2020 ·Cancer ·Areej El‐Jawahri, Jamie M. Jacobs, Ashley M. Nelson, Lara Traeger, Joseph A. Greer, (unknown), Lauren Waldman, (unknown), (unknown), (unknown), Nora Horick, Thomas R. Spitzer, Zachariah DeFilipp, (unknown), Jennifer S. Temel	42
19	Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma 2019 ·Blood ·Matthew J. Frigault, Jörg Dietrich, María Martínez-Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, (unknown), Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus	160
20	Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation 2018 ·Biology of Blood and Marrow Transplantation ·Zachariah DeFilipp, Elizabeth Hohmann, Robert R. Jenq, Yi‐Bin Chen	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact